Aurobindo Pharma Ltd has divested its step-down subsidiary, Aurobindo Pharma (Australia) Pty Ltd to Eris Pharma Australia Pty Ltd.
The Hyderabad – based Aurobindo will, however, under an agreement continue to manufacture and supply the products to Eris Pharma for Australian and New Zealand market over next few years.
“This divestment is in line with APL’s Strategy of focusing on US, EU and Key Emerging Markets,” the Bombay Stock Exchange was informed on Friday.
The subsidiary was not contributing any profit to Aurobindo, it added.
By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…
By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital …
Kurnool, November 20, 2024: Adoni, Andhra Pradesh, – The Khazi India Foundation is pleased to…
New Delhi, November 20, 2024: Aakash Healthcare marked this year’s Children’s Day with a joyful…
Dr Agarwals Eye Hospital, Bengaluru, is providing free consultations for diabetic patients aged 50 and…
By Ms. Archana S, Senior Nutritionist, Aster Whitefield Hospital, Bengaluru As an essential nutrient, protein…